| Market Cap | ₹2,900Cr |
| ROE | 11.57% |
| P/E Ratio(TTM) | 34.37 |
| EPS(TTM) | 9.01 |
| P/B Ratio | 3.98 |
| Dividend Yield | 0.12% |
| Industry P/E | 32.43 |
| Book Value | 77.88 |
| Debt to Equity | 0.44 |
| Face Value | 1 |
| Managing Director | Sri. Ramesh Babu Potluri |
| Founded | 1987 |
| NSE Symbol | SMSPHARMA |
| FUND NAME | AUM(%) |
|---|---|
| Quant Small Cap Fund Direct Plan Growth | 0.19% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 64.20 | ||
| Neuland Laboratories | NA (0.00%) | 72.55 | ||
| Jubilant Pharmova | NA (0.00%) | 31.91 | ||
| Acutaas Chemicals | NA (0.00%) | 58.94 |